Peer AI Strengthens Leadership with David Florez as Sales VP

Peer AI, an emerging leader in the AI landscape for life sciences regulatory documentation, has taken a significant step forward by appointing David Florez as its new Vice President of Sales. This strategic move comes at a time when life science companies are actively transitioning from AI pilot projects to full-scale implementations in their operations. Florez is expected to spearhead the company's go-to-market strategy, thereby boosting the utilization of AI in regulatory intelligence while also focusing on enhancing customer relationships.

As the need for transformation within regulatory workflows escalates, Florez's expertise will be instrumental. He brings to the table years of experience, including a commendable six-year tenure at Veeva Systems, where he collaborated with pharmaceutical and biotech companies to introduce cloud solutions across various domains, including clinical trials and regulatory affairs. His proven track record in navigating transitions during significant technological advancements aligns perfectly with Peer AI's mission.

Anita Modi, the CEO and co-founder of Peer AI, emphasized the importance of governance, validation, change management, and organizational alignment in successful AI implementation. She stated, “David’s comprehensive understanding of the life sciences ecosystem and his successful history in driving market-ready strategies will be key in fostering customer success as we continue to expand.” The company aims to help clients maneuver through the often complex and regulated landscape of life sciences documentation.

Florez echoed his commitment to the industry by addressing common issues faced by companies dealing with regulatory documentation. He remarked, “I’ve observed numerous companies encountering bottlenecks in the documentation process, despite having access to sophisticated content and data management systems. It's an area that is clearly ripe for change. I am dedicated to enabling the industry to unlock the value of agentic AI and to catapult regulatory processes into a new era.”

The Peer AI platform is dedicated to revolutionizing regulatory documentation by employing specialized AI agents designed specifically for the life sciences sector. This innovative technology automates the creation of critical documents such as clinical study reports, investigational new drug applications, and more, permitting medical professionals to maintain oversight while streamlining the workflow.

As major pharmaceutical companies and burgeoning biotech firms continue to adopt this platform, they are reportedly saving considerable amounts of time and enhancing the quality of their regulatory documents across various stages of development.

Florez and the Peer AI team will showcase their advancements at the upcoming DIA Regulatory Submissions, Information, and Document Management Forum taking place from February 2-4, 2026. Attendees can visit their booth for a live demonstration of the platform and to learn how AI can modernize regulatory processes.

For detailed insights about Peer AI and its contributions to life sciences, visit getpeer.ai. The company's commitment to innovation in regulatory workflows positions it as a vital player in a rapidly evolving industry, linking strategic leadership with technological advancement to foster industry-wide transformations.